Hemodynamic changes after cardioversion of chronic atrial fibrillation
- PMID: 9164372
Hemodynamic changes after cardioversion of chronic atrial fibrillation
Abstract
After cardioversion of chronic atrial fibrillation to sinus rhythm, there is a gradual increase of 56% in cardiac output over 4 weeks. The increase is caused by the gradual return and increasing strength of left atrial mechanical activity as the atrial myopathy of chronic atrial fibrillation subsides. Cardiac output decreases after cardioversion of atrial fibrillation in more than a third of patients, and the decrease may last a week. Acute pulmonary edema is uncommon; 50% of cases occur within 3 hours of cardioversion, with a mortality of 18%. The reduced cardiac performance after cardioversion most likely results from the combination of heart disease and cardiac depressant effects of anesthetic drugs used. Pulmonary and/or coronary artery emboli and the resumption of right atrial mechanical activity before left atrial mechanical activity may be additional factors in the pathogenesis of pulmonary edema after cardioversion. Anticoagulant therapy should be continued for a month or longer after cardioversion in those patients who maintain sinus rhythm to prevent thromboembolism.
Comment in
-
Acute pulmonary edema after overdrive for atrial flutter.Arch Intern Med. 1998 Mar 23;158(6):679-80. doi: 10.1001/archinte.158.6.679. Arch Intern Med. 1998. PMID: 9521233 No abstract available.
Similar articles
-
Functional capacity of patients with atrial fibrillation and controlled heart rate before and after cardioversion.Can J Cardiol. 1992 Nov;8(9):941-6. Can J Cardiol. 1992. PMID: 1486544 Clinical Trial.
-
Atrial fibrillation: rate control often better than rhythm control.Prescrire Int. 2004 Apr;13(70):64-9. Prescrire Int. 2004. PMID: 15148984
-
[Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].G Ital Cardiol. 1997 Aug;27(8):803-10. G Ital Cardiol. 1997. PMID: 9312508 Italian.
-
Anticoagulation for cardioversion of atrial fibrillation.Minerva Cardioangiol. 2002 Feb;50(1):43-52. Minerva Cardioangiol. 2002. PMID: 11830718 Review.
-
[Drug and electrical therapy of supraventricular tachyarrhythmias].Z Kardiol. 2000;89 Suppl 3:68-74. Z Kardiol. 2000. PMID: 10810788 Review. German.
Cited by
-
Cost effectiveness of therapies for atrial fibrillation. A review.Pharmacoeconomics. 2000 Oct;18(4):317-33. doi: 10.2165/00019053-200018040-00002. Pharmacoeconomics. 2000. PMID: 15344302 Review.
-
Cardioversion and the use of sedation.Heart. 2004 Dec;90(12):1374-6. doi: 10.1136/hrt.2004.040113. Heart. 2004. PMID: 15547004 Free PMC article.
-
Atrial fibrillation and dementia: not just a coincidence.J Geriatr Cardiol. 2023 Sep 28;20(9):697-701. doi: 10.26599/1671-5411.2023.09.003. J Geriatr Cardiol. 2023. PMID: 37840632 Free PMC article. No abstract available.
-
Pulmonary edema post-cardioversion: a potential calcium signalling problem.Can J Cardiol. 2006 Mar 1;22(3):259-62. doi: 10.1016/s0828-282x(06)70907-2. Can J Cardiol. 2006. PMID: 16520859 Free PMC article.
-
Anti-thrombotic strategies for patients with atrial fibrillation and heart failure.Heart Fail Rev. 2002 Jul;7(3):261-6. doi: 10.1023/a:1020081327269. Heart Fail Rev. 2002. PMID: 12215731 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical